The Office for Life Sciences (OLS) has launched a Biomanufacturing Fund (BMF) to support life science companies investing in manufacturing projects in the UK. The BMF will provide up to £38m in capital grants to incentivise investment in the manufacture of vaccines and biotherapeutics, to improve the UK’s health resilience for future pandemics.
The BMF follows on from the £60m Life Sciences Innovative Manufacturing Fund (LSIMF) and will be using the same process as LSIMF for delivering the grants.
There are two upcoming opportunities to apply, with monthly deadlines of 30th June and 31st July. If you think you could benefit from this fund please contact the BMF team at: bmf@officeforlifesciences.gov.uk.
Read more here